T11	Treatment 25 36	clindamycin
T12	Subject 0 11	One patient
T15	Population 0 3	One
T16	Severity_cue 66 72	marked
T13	Effect 66 158	marked cholestasis, portal inflammation, bile duct injury and bile duct paucity (ductopenia)
T17	Drug 25 36	clindamycin
T14	Adverse_event 37 40	had
E1	Adverse_event:T14 
A1	Severity E1 High